Bayer recruits oncology vet Christine Roth from GSK to lead oncology business unit
Bayer has a new head of oncology in its pharmaceuticals division — and she comes from GSK.
Christine Roth, a former senior VP and head of oncology at GSK, will be leading Bayer’s oncology strategic business unit while based in the US, the pharma announced. And she’s arriving on the heels of new Phase III data that could give their cancer blockbuster hopeful Nubeqa a better shot at marketing glory.
Keep reading Endpoints with a free subscription
Unlock this story instantly and join 153,800+ biopharma pros reading Endpoints daily — and it's free.